| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |